Progressive cognitive impairment and its neuropathologic correlates /:
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York :
Nova Biomedical,
[2016]
|
| Schriftenreihe: | Neurodevelopmental diseases--laboratory and clinical research series.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 online resource. |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9781634852975 1634852974 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn958984679 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 160415s2016 nyua ob 001 0 eng | ||
| 010 | |a 2019721377 | ||
| 040 | |a DLC |b eng |e rda |c DLC |d N$T |d EBLCP |d OCLCF |d SNK |d DKU |d AUW |d IGB |d D6H |d VTS |d AGLDB |d AU@ |d G3B |d S8J |d S9I |d STF |d OCLCO |d OCLCQ |d OCLCO |d OCLCL | ||
| 020 | |a 9781634852975 |q pdf | ||
| 020 | |a 1634852974 | ||
| 020 | |z 9781634852210 |q hardcover | ||
| 035 | |a (OCoLC)958984679 | ||
| 050 | 0 | 0 | |a RC365 |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 7 | |a 616.8/047 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Progressive cognitive impairment and its neuropathologic correlates / |c Gediminas Peter Gliebus, editor. |
| 264 | 1 | |a New York : |b Nova Biomedical, |c [2016] | |
| 300 | |a 1 online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 490 | 1 | |a Neurodevelopmental diseases--laboratory and clinical research | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | |a Description based on print version record. | ||
| 505 | 0 | |a PROGRESSIVE COGNITIVE IMPAIRMENT AND ITS NEUROPATHOLOGIC CORRELATES; PROGRESSIVE COGNITIVE IMPAIRMENT AND ITS NEUROPATHOLOGIC CORRELATES; Library of Congress Cataloging-in-Publication Data; CONTENTS; FOREWORD; INTRODUCTION; Chapter 1: NEUROPATHOLOGY OF NEURODEGENERATIVE DISORDERS; ABSTRACT; BRAIN EXAMINATION AND SECTIONS; ALZHEIMER DISEASE NEUROPATHOLOGIC CHANGE; LEWY BODY DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; PICK DISEASE (FTLD-TAU, PID); PROGRESSIVE SUPRANUCLEAR PALSY (FTLD-TAU, PSP); CORTICOBASAL DEGENERATION (FTLD-TAU, CBD) | |
| 505 | 8 | |a FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP-43 PROTEINOPATHY (FTLD-TDP)FTLD-FUS; PRION DISEASE; SUMMARY; REFERENCES; Chapter 2: IMAGING AND CEREBROSPINAL FLUID BIOMARKERS IN ALZHEIMER'S DISEASE AND LEWY BODY SPECTRUM DISORDERS; ABSTRACT; GLOSSARY; 1. INTRODUCTION; 2. BIOMARKERS DERIVED FROM STRUCTURAL MAGNETIC RESONANCE IMAGING (MRI) IN AD AND LBD; 2.1. Cross-sectional Profiles of Cerebral Atrophy; 2.2. Longitudinal Rates of Cerebral Atrophy; 2.3. Atrophy Patterns in Medial Temporal Lobe Structures; 2.3.1. Hippocampus; 2.3.2. Entorhinal Cortex; 2.3.3. Subcortical Structures | |
| 505 | 8 | |a 2.4. White Matter Hyperintensities3. BIOMARKERS DERIVED FROM DIFFUSION TENSOR IMAGING (DTI) IN AD AND LBD; 4. BIOMARKERS DERIVED FROM POSITRON EMISSION TOMOGRAPHY (PET) IN AD AND LBD; 4.1. Role of FDG-PET; 4.2. Role of Amyloid PET; 4.3. Role of Acetylcholine Esterase Activity on PET; 5. BIOMARKERS DERIVED FROM SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN AD AND LBD; 6. PROTON MAGNETIC RESONANCE SPECTROSCOPY (1H-MRS) AS A BIOMARKER IN AD AND LBD; 7. BIOMARKERS DERIVED FROM FUNCTIONAL MAGNETIC RESONANCE IMAGING (FMRI) IN AD AND LBD | |
| 505 | 8 | |a 8. [123I]METAIODOBENZYLGUANIDINE ([123I]MIBG) MYOCARDIAL SCINTIGRAPHY TO ASSESS AUTONOMIC DYSFUNCTION IN AD AND LBD9. CEREBROSPINAL FLUID (CSF) BIOMARKERS IN AD AND LBD; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter 3: FUNCTION AND DYSFUNCTION OF THE PREFRONTAL LOBES IN NEURODEGENERATIVE DISEASES; ABSTRACT; TERMINOLOGY; NEUROANATOMY OF PREFRONTAL FUNCTIONS; Stuss' Model of Prefrontal Function; Cortico-Striato-Pallido-Thalamo-Cortical Loops; Integration of the Two Models; Larger-Scale Frontal Networks; CLINICAL ASSESSMENT OF PREFRONTAL FUNCTIONS; Dorsolateral Prefrontal Functions | |
| 505 | 8 | |a Medial Prefrontal FunctionsOrbitofrontal Functions; Frontal Polar Functions; DISORDERS OF PREFRONTAL FUNCTIONS IN NEURODEGENERATIVE DISEASES; Subcortical Dementias; Behavioural Variant Frontotemporal Dementia (bvFTD); Behavioural/Dysexecutive Variant of Alzheimer's Disease; ACKNOWLEDGMENTS; REFERENCES; Chapter 4: ACTION-INTENTIONAL DISORDERS IN NEURODEGENERATIVE DISEASES; ABSTRACT; MOVEMENT-ACTION PROGRAMMING: "HOW" AND "WHEN"; RELATIONSHIPS BETWEEN COMPONENTS OF SENSORY-ATTENTION AND ACTION-INTENTION; ACTION-INTENTIONAL DISORDERS; Impaired Initiation; Akinesia; Defective Response Inhibition | |
| 650 | 0 | |a Nervous system |x Degeneration. |0 http://id.loc.gov/authorities/subjects/sh85090923 | |
| 650 | 2 | |a Neurodegenerative Diseases |0 https://id.nlm.nih.gov/mesh/D019636 | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / General |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Clinical Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Diseases |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Evidence-Based Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Internal Medicine |2 bisacsh | |
| 650 | 7 | |a Nervous system |x Degeneration |2 fast | |
| 700 | 1 | |a Gliebus, Gediminas Peter, |e editor. | |
| 758 | |i has work: |a Progressive Cognitive Impairment and Its Neuropathologic Correlates (Text) |1 https://id.oclc.org/worldcat/entity/E39PD3y3jtw9DvhqmYtdTYhQ9C |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Progressive cognitive impairment and its neuropathologic correlates |d New York : Nova Biomedical, [2016] |z 9781634852210 (hardcover) |w (DLC) 2016939079 |
| 830 | 0 | |a Neurodevelopmental diseases--laboratory and clinical research series. |0 http://id.loc.gov/authorities/names/no2009154657 | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1356586 |3 Volltext |
| 938 | |a EBSCOhost |b EBSC |n 1356586 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL4698073 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn958984679 |
|---|---|
| _version_ | 1816882362488717312 |
| adam_text | |
| any_adam_object | |
| author2 | Gliebus, Gediminas Peter |
| author2_role | edt |
| author2_variant | g p g gp gpg |
| author_facet | Gliebus, Gediminas Peter |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC365 |
| callnumber-raw | RC365 |
| callnumber-search | RC365 |
| callnumber-sort | RC 3365 |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| contents | PROGRESSIVE COGNITIVE IMPAIRMENT AND ITS NEUROPATHOLOGIC CORRELATES; PROGRESSIVE COGNITIVE IMPAIRMENT AND ITS NEUROPATHOLOGIC CORRELATES; Library of Congress Cataloging-in-Publication Data; CONTENTS; FOREWORD; INTRODUCTION; Chapter 1: NEUROPATHOLOGY OF NEURODEGENERATIVE DISORDERS; ABSTRACT; BRAIN EXAMINATION AND SECTIONS; ALZHEIMER DISEASE NEUROPATHOLOGIC CHANGE; LEWY BODY DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; PICK DISEASE (FTLD-TAU, PID); PROGRESSIVE SUPRANUCLEAR PALSY (FTLD-TAU, PSP); CORTICOBASAL DEGENERATION (FTLD-TAU, CBD) FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP-43 PROTEINOPATHY (FTLD-TDP)FTLD-FUS; PRION DISEASE; SUMMARY; REFERENCES; Chapter 2: IMAGING AND CEREBROSPINAL FLUID BIOMARKERS IN ALZHEIMER'S DISEASE AND LEWY BODY SPECTRUM DISORDERS; ABSTRACT; GLOSSARY; 1. INTRODUCTION; 2. BIOMARKERS DERIVED FROM STRUCTURAL MAGNETIC RESONANCE IMAGING (MRI) IN AD AND LBD; 2.1. Cross-sectional Profiles of Cerebral Atrophy; 2.2. Longitudinal Rates of Cerebral Atrophy; 2.3. Atrophy Patterns in Medial Temporal Lobe Structures; 2.3.1. Hippocampus; 2.3.2. Entorhinal Cortex; 2.3.3. Subcortical Structures 2.4. White Matter Hyperintensities3. BIOMARKERS DERIVED FROM DIFFUSION TENSOR IMAGING (DTI) IN AD AND LBD; 4. BIOMARKERS DERIVED FROM POSITRON EMISSION TOMOGRAPHY (PET) IN AD AND LBD; 4.1. Role of FDG-PET; 4.2. Role of Amyloid PET; 4.3. Role of Acetylcholine Esterase Activity on PET; 5. BIOMARKERS DERIVED FROM SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN AD AND LBD; 6. PROTON MAGNETIC RESONANCE SPECTROSCOPY (1H-MRS) AS A BIOMARKER IN AD AND LBD; 7. BIOMARKERS DERIVED FROM FUNCTIONAL MAGNETIC RESONANCE IMAGING (FMRI) IN AD AND LBD 8. [123I]METAIODOBENZYLGUANIDINE ([123I]MIBG) MYOCARDIAL SCINTIGRAPHY TO ASSESS AUTONOMIC DYSFUNCTION IN AD AND LBD9. CEREBROSPINAL FLUID (CSF) BIOMARKERS IN AD AND LBD; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter 3: FUNCTION AND DYSFUNCTION OF THE PREFRONTAL LOBES IN NEURODEGENERATIVE DISEASES; ABSTRACT; TERMINOLOGY; NEUROANATOMY OF PREFRONTAL FUNCTIONS; Stuss' Model of Prefrontal Function; Cortico-Striato-Pallido-Thalamo-Cortical Loops; Integration of the Two Models; Larger-Scale Frontal Networks; CLINICAL ASSESSMENT OF PREFRONTAL FUNCTIONS; Dorsolateral Prefrontal Functions Medial Prefrontal FunctionsOrbitofrontal Functions; Frontal Polar Functions; DISORDERS OF PREFRONTAL FUNCTIONS IN NEURODEGENERATIVE DISEASES; Subcortical Dementias; Behavioural Variant Frontotemporal Dementia (bvFTD); Behavioural/Dysexecutive Variant of Alzheimer's Disease; ACKNOWLEDGMENTS; REFERENCES; Chapter 4: ACTION-INTENTIONAL DISORDERS IN NEURODEGENERATIVE DISEASES; ABSTRACT; MOVEMENT-ACTION PROGRAMMING: "HOW" AND "WHEN"; RELATIONSHIPS BETWEEN COMPONENTS OF SENSORY-ATTENTION AND ACTION-INTENTION; ACTION-INTENTIONAL DISORDERS; Impaired Initiation; Akinesia; Defective Response Inhibition |
| ctrlnum | (OCoLC)958984679 |
| dewey-full | 616.8/047 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.8/047 |
| dewey-search | 616.8/047 |
| dewey-sort | 3616.8 247 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05577cam a2200637 i 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn958984679</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">160415s2016 nyua ob 001 0 eng </controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2019721377</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DLC</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">DLC</subfield><subfield code="d">N$T</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCF</subfield><subfield code="d">SNK</subfield><subfield code="d">DKU</subfield><subfield code="d">AUW</subfield><subfield code="d">IGB</subfield><subfield code="d">D6H</subfield><subfield code="d">VTS</subfield><subfield code="d">AGLDB</subfield><subfield code="d">AU@</subfield><subfield code="d">G3B</subfield><subfield code="d">S8J</subfield><subfield code="d">S9I</subfield><subfield code="d">STF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781634852975</subfield><subfield code="q">pdf</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1634852974</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781634852210</subfield><subfield code="q">hardcover</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)958984679</subfield></datafield><datafield tag="050" ind1="0" ind2="0"><subfield code="a">RC365</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HEA</subfield><subfield code="x">039000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">014000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">022000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">112000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">045000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.8/047</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Progressive cognitive impairment and its neuropathologic correlates /</subfield><subfield code="c">Gediminas Peter Gliebus, editor.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York :</subfield><subfield code="b">Nova Biomedical,</subfield><subfield code="c">[2016]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">data file</subfield><subfield code="2">rda</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Neurodevelopmental diseases--laboratory and clinical research</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on print version record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">PROGRESSIVE COGNITIVE IMPAIRMENT AND ITS NEUROPATHOLOGIC CORRELATES; PROGRESSIVE COGNITIVE IMPAIRMENT AND ITS NEUROPATHOLOGIC CORRELATES; Library of Congress Cataloging-in-Publication Data; CONTENTS; FOREWORD; INTRODUCTION; Chapter 1: NEUROPATHOLOGY OF NEURODEGENERATIVE DISORDERS; ABSTRACT; BRAIN EXAMINATION AND SECTIONS; ALZHEIMER DISEASE NEUROPATHOLOGIC CHANGE; LEWY BODY DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; PICK DISEASE (FTLD-TAU, PID); PROGRESSIVE SUPRANUCLEAR PALSY (FTLD-TAU, PSP); CORTICOBASAL DEGENERATION (FTLD-TAU, CBD)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP-43 PROTEINOPATHY (FTLD-TDP)FTLD-FUS; PRION DISEASE; SUMMARY; REFERENCES; Chapter 2: IMAGING AND CEREBROSPINAL FLUID BIOMARKERS IN ALZHEIMER'S DISEASE AND LEWY BODY SPECTRUM DISORDERS; ABSTRACT; GLOSSARY; 1. INTRODUCTION; 2. BIOMARKERS DERIVED FROM STRUCTURAL MAGNETIC RESONANCE IMAGING (MRI) IN AD AND LBD; 2.1. Cross-sectional Profiles of Cerebral Atrophy; 2.2. Longitudinal Rates of Cerebral Atrophy; 2.3. Atrophy Patterns in Medial Temporal Lobe Structures; 2.3.1. Hippocampus; 2.3.2. Entorhinal Cortex; 2.3.3. Subcortical Structures</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">2.4. White Matter Hyperintensities3. BIOMARKERS DERIVED FROM DIFFUSION TENSOR IMAGING (DTI) IN AD AND LBD; 4. BIOMARKERS DERIVED FROM POSITRON EMISSION TOMOGRAPHY (PET) IN AD AND LBD; 4.1. Role of FDG-PET; 4.2. Role of Amyloid PET; 4.3. Role of Acetylcholine Esterase Activity on PET; 5. BIOMARKERS DERIVED FROM SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN AD AND LBD; 6. PROTON MAGNETIC RESONANCE SPECTROSCOPY (1H-MRS) AS A BIOMARKER IN AD AND LBD; 7. BIOMARKERS DERIVED FROM FUNCTIONAL MAGNETIC RESONANCE IMAGING (FMRI) IN AD AND LBD</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">8. [123I]METAIODOBENZYLGUANIDINE ([123I]MIBG) MYOCARDIAL SCINTIGRAPHY TO ASSESS AUTONOMIC DYSFUNCTION IN AD AND LBD9. CEREBROSPINAL FLUID (CSF) BIOMARKERS IN AD AND LBD; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter 3: FUNCTION AND DYSFUNCTION OF THE PREFRONTAL LOBES IN NEURODEGENERATIVE DISEASES; ABSTRACT; TERMINOLOGY; NEUROANATOMY OF PREFRONTAL FUNCTIONS; Stuss' Model of Prefrontal Function; Cortico-Striato-Pallido-Thalamo-Cortical Loops; Integration of the Two Models; Larger-Scale Frontal Networks; CLINICAL ASSESSMENT OF PREFRONTAL FUNCTIONS; Dorsolateral Prefrontal Functions</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Medial Prefrontal FunctionsOrbitofrontal Functions; Frontal Polar Functions; DISORDERS OF PREFRONTAL FUNCTIONS IN NEURODEGENERATIVE DISEASES; Subcortical Dementias; Behavioural Variant Frontotemporal Dementia (bvFTD); Behavioural/Dysexecutive Variant of Alzheimer's Disease; ACKNOWLEDGMENTS; REFERENCES; Chapter 4: ACTION-INTENTIONAL DISORDERS IN NEURODEGENERATIVE DISEASES; ABSTRACT; MOVEMENT-ACTION PROGRAMMING: "HOW" AND "WHEN"; RELATIONSHIPS BETWEEN COMPONENTS OF SENSORY-ATTENTION AND ACTION-INTENTION; ACTION-INTENTIONAL DISORDERS; Impaired Initiation; Akinesia; Defective Response Inhibition</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Nervous system</subfield><subfield code="x">Degeneration.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85090923</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Neurodegenerative Diseases</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D019636</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Clinical Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Diseases</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Evidence-Based Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Internal Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nervous system</subfield><subfield code="x">Degeneration</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gliebus, Gediminas Peter,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Progressive Cognitive Impairment and Its Neuropathologic Correlates (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PD3y3jtw9DvhqmYtdTYhQ9C</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Progressive cognitive impairment and its neuropathologic correlates</subfield><subfield code="d">New York : Nova Biomedical, [2016]</subfield><subfield code="z">9781634852210 (hardcover)</subfield><subfield code="w">(DLC) 2016939079</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Neurodevelopmental diseases--laboratory and clinical research series.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2009154657</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1356586</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">1356586</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL4698073</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-ocn958984679 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:27:24Z |
| institution | BVB |
| isbn | 9781634852975 1634852974 |
| language | English |
| lccn | 2019721377 |
| oclc_num | 958984679 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource. |
| psigel | ZDB-4-EBA |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | Nova Biomedical, |
| record_format | marc |
| series | Neurodevelopmental diseases--laboratory and clinical research series. |
| series2 | Neurodevelopmental diseases--laboratory and clinical research |
| spelling | Progressive cognitive impairment and its neuropathologic correlates / Gediminas Peter Gliebus, editor. New York : Nova Biomedical, [2016] 1 online resource. text txt rdacontent computer c rdamedia online resource cr rdacarrier data file rda Neurodevelopmental diseases--laboratory and clinical research Includes bibliographical references and index. Description based on print version record. PROGRESSIVE COGNITIVE IMPAIRMENT AND ITS NEUROPATHOLOGIC CORRELATES; PROGRESSIVE COGNITIVE IMPAIRMENT AND ITS NEUROPATHOLOGIC CORRELATES; Library of Congress Cataloging-in-Publication Data; CONTENTS; FOREWORD; INTRODUCTION; Chapter 1: NEUROPATHOLOGY OF NEURODEGENERATIVE DISORDERS; ABSTRACT; BRAIN EXAMINATION AND SECTIONS; ALZHEIMER DISEASE NEUROPATHOLOGIC CHANGE; LEWY BODY DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; PICK DISEASE (FTLD-TAU, PID); PROGRESSIVE SUPRANUCLEAR PALSY (FTLD-TAU, PSP); CORTICOBASAL DEGENERATION (FTLD-TAU, CBD) FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP-43 PROTEINOPATHY (FTLD-TDP)FTLD-FUS; PRION DISEASE; SUMMARY; REFERENCES; Chapter 2: IMAGING AND CEREBROSPINAL FLUID BIOMARKERS IN ALZHEIMER'S DISEASE AND LEWY BODY SPECTRUM DISORDERS; ABSTRACT; GLOSSARY; 1. INTRODUCTION; 2. BIOMARKERS DERIVED FROM STRUCTURAL MAGNETIC RESONANCE IMAGING (MRI) IN AD AND LBD; 2.1. Cross-sectional Profiles of Cerebral Atrophy; 2.2. Longitudinal Rates of Cerebral Atrophy; 2.3. Atrophy Patterns in Medial Temporal Lobe Structures; 2.3.1. Hippocampus; 2.3.2. Entorhinal Cortex; 2.3.3. Subcortical Structures 2.4. White Matter Hyperintensities3. BIOMARKERS DERIVED FROM DIFFUSION TENSOR IMAGING (DTI) IN AD AND LBD; 4. BIOMARKERS DERIVED FROM POSITRON EMISSION TOMOGRAPHY (PET) IN AD AND LBD; 4.1. Role of FDG-PET; 4.2. Role of Amyloid PET; 4.3. Role of Acetylcholine Esterase Activity on PET; 5. BIOMARKERS DERIVED FROM SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN AD AND LBD; 6. PROTON MAGNETIC RESONANCE SPECTROSCOPY (1H-MRS) AS A BIOMARKER IN AD AND LBD; 7. BIOMARKERS DERIVED FROM FUNCTIONAL MAGNETIC RESONANCE IMAGING (FMRI) IN AD AND LBD 8. [123I]METAIODOBENZYLGUANIDINE ([123I]MIBG) MYOCARDIAL SCINTIGRAPHY TO ASSESS AUTONOMIC DYSFUNCTION IN AD AND LBD9. CEREBROSPINAL FLUID (CSF) BIOMARKERS IN AD AND LBD; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter 3: FUNCTION AND DYSFUNCTION OF THE PREFRONTAL LOBES IN NEURODEGENERATIVE DISEASES; ABSTRACT; TERMINOLOGY; NEUROANATOMY OF PREFRONTAL FUNCTIONS; Stuss' Model of Prefrontal Function; Cortico-Striato-Pallido-Thalamo-Cortical Loops; Integration of the Two Models; Larger-Scale Frontal Networks; CLINICAL ASSESSMENT OF PREFRONTAL FUNCTIONS; Dorsolateral Prefrontal Functions Medial Prefrontal FunctionsOrbitofrontal Functions; Frontal Polar Functions; DISORDERS OF PREFRONTAL FUNCTIONS IN NEURODEGENERATIVE DISEASES; Subcortical Dementias; Behavioural Variant Frontotemporal Dementia (bvFTD); Behavioural/Dysexecutive Variant of Alzheimer's Disease; ACKNOWLEDGMENTS; REFERENCES; Chapter 4: ACTION-INTENTIONAL DISORDERS IN NEURODEGENERATIVE DISEASES; ABSTRACT; MOVEMENT-ACTION PROGRAMMING: "HOW" AND "WHEN"; RELATIONSHIPS BETWEEN COMPONENTS OF SENSORY-ATTENTION AND ACTION-INTENTION; ACTION-INTENTIONAL DISORDERS; Impaired Initiation; Akinesia; Defective Response Inhibition Nervous system Degeneration. http://id.loc.gov/authorities/subjects/sh85090923 Neurodegenerative Diseases https://id.nlm.nih.gov/mesh/D019636 HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Nervous system Degeneration fast Gliebus, Gediminas Peter, editor. has work: Progressive Cognitive Impairment and Its Neuropathologic Correlates (Text) https://id.oclc.org/worldcat/entity/E39PD3y3jtw9DvhqmYtdTYhQ9C https://id.oclc.org/worldcat/ontology/hasWork Print version: Progressive cognitive impairment and its neuropathologic correlates New York : Nova Biomedical, [2016] 9781634852210 (hardcover) (DLC) 2016939079 Neurodevelopmental diseases--laboratory and clinical research series. http://id.loc.gov/authorities/names/no2009154657 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1356586 Volltext |
| spellingShingle | Progressive cognitive impairment and its neuropathologic correlates / Neurodevelopmental diseases--laboratory and clinical research series. PROGRESSIVE COGNITIVE IMPAIRMENT AND ITS NEUROPATHOLOGIC CORRELATES; PROGRESSIVE COGNITIVE IMPAIRMENT AND ITS NEUROPATHOLOGIC CORRELATES; Library of Congress Cataloging-in-Publication Data; CONTENTS; FOREWORD; INTRODUCTION; Chapter 1: NEUROPATHOLOGY OF NEURODEGENERATIVE DISORDERS; ABSTRACT; BRAIN EXAMINATION AND SECTIONS; ALZHEIMER DISEASE NEUROPATHOLOGIC CHANGE; LEWY BODY DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; PICK DISEASE (FTLD-TAU, PID); PROGRESSIVE SUPRANUCLEAR PALSY (FTLD-TAU, PSP); CORTICOBASAL DEGENERATION (FTLD-TAU, CBD) FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP-43 PROTEINOPATHY (FTLD-TDP)FTLD-FUS; PRION DISEASE; SUMMARY; REFERENCES; Chapter 2: IMAGING AND CEREBROSPINAL FLUID BIOMARKERS IN ALZHEIMER'S DISEASE AND LEWY BODY SPECTRUM DISORDERS; ABSTRACT; GLOSSARY; 1. INTRODUCTION; 2. BIOMARKERS DERIVED FROM STRUCTURAL MAGNETIC RESONANCE IMAGING (MRI) IN AD AND LBD; 2.1. Cross-sectional Profiles of Cerebral Atrophy; 2.2. Longitudinal Rates of Cerebral Atrophy; 2.3. Atrophy Patterns in Medial Temporal Lobe Structures; 2.3.1. Hippocampus; 2.3.2. Entorhinal Cortex; 2.3.3. Subcortical Structures 2.4. White Matter Hyperintensities3. BIOMARKERS DERIVED FROM DIFFUSION TENSOR IMAGING (DTI) IN AD AND LBD; 4. BIOMARKERS DERIVED FROM POSITRON EMISSION TOMOGRAPHY (PET) IN AD AND LBD; 4.1. Role of FDG-PET; 4.2. Role of Amyloid PET; 4.3. Role of Acetylcholine Esterase Activity on PET; 5. BIOMARKERS DERIVED FROM SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN AD AND LBD; 6. PROTON MAGNETIC RESONANCE SPECTROSCOPY (1H-MRS) AS A BIOMARKER IN AD AND LBD; 7. BIOMARKERS DERIVED FROM FUNCTIONAL MAGNETIC RESONANCE IMAGING (FMRI) IN AD AND LBD 8. [123I]METAIODOBENZYLGUANIDINE ([123I]MIBG) MYOCARDIAL SCINTIGRAPHY TO ASSESS AUTONOMIC DYSFUNCTION IN AD AND LBD9. CEREBROSPINAL FLUID (CSF) BIOMARKERS IN AD AND LBD; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter 3: FUNCTION AND DYSFUNCTION OF THE PREFRONTAL LOBES IN NEURODEGENERATIVE DISEASES; ABSTRACT; TERMINOLOGY; NEUROANATOMY OF PREFRONTAL FUNCTIONS; Stuss' Model of Prefrontal Function; Cortico-Striato-Pallido-Thalamo-Cortical Loops; Integration of the Two Models; Larger-Scale Frontal Networks; CLINICAL ASSESSMENT OF PREFRONTAL FUNCTIONS; Dorsolateral Prefrontal Functions Medial Prefrontal FunctionsOrbitofrontal Functions; Frontal Polar Functions; DISORDERS OF PREFRONTAL FUNCTIONS IN NEURODEGENERATIVE DISEASES; Subcortical Dementias; Behavioural Variant Frontotemporal Dementia (bvFTD); Behavioural/Dysexecutive Variant of Alzheimer's Disease; ACKNOWLEDGMENTS; REFERENCES; Chapter 4: ACTION-INTENTIONAL DISORDERS IN NEURODEGENERATIVE DISEASES; ABSTRACT; MOVEMENT-ACTION PROGRAMMING: "HOW" AND "WHEN"; RELATIONSHIPS BETWEEN COMPONENTS OF SENSORY-ATTENTION AND ACTION-INTENTION; ACTION-INTENTIONAL DISORDERS; Impaired Initiation; Akinesia; Defective Response Inhibition Nervous system Degeneration. http://id.loc.gov/authorities/subjects/sh85090923 Neurodegenerative Diseases https://id.nlm.nih.gov/mesh/D019636 HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Nervous system Degeneration fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85090923 https://id.nlm.nih.gov/mesh/D019636 |
| title | Progressive cognitive impairment and its neuropathologic correlates / |
| title_auth | Progressive cognitive impairment and its neuropathologic correlates / |
| title_exact_search | Progressive cognitive impairment and its neuropathologic correlates / |
| title_full | Progressive cognitive impairment and its neuropathologic correlates / Gediminas Peter Gliebus, editor. |
| title_fullStr | Progressive cognitive impairment and its neuropathologic correlates / Gediminas Peter Gliebus, editor. |
| title_full_unstemmed | Progressive cognitive impairment and its neuropathologic correlates / Gediminas Peter Gliebus, editor. |
| title_short | Progressive cognitive impairment and its neuropathologic correlates / |
| title_sort | progressive cognitive impairment and its neuropathologic correlates |
| topic | Nervous system Degeneration. http://id.loc.gov/authorities/subjects/sh85090923 Neurodegenerative Diseases https://id.nlm.nih.gov/mesh/D019636 HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Nervous system Degeneration fast |
| topic_facet | Nervous system Degeneration. Neurodegenerative Diseases HEALTH & FITNESS / Diseases / General MEDICAL / Clinical Medicine MEDICAL / Diseases MEDICAL / Evidence-Based Medicine MEDICAL / Internal Medicine Nervous system Degeneration |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1356586 |
| work_keys_str_mv | AT gliebusgediminaspeter progressivecognitiveimpairmentanditsneuropathologiccorrelates |